BlackRock, Inc. 13D and 13G filings for Amgen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
40,830,830 7.600% |
-6,980,526 (-14.60%) |
Filing |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
47,811,356 8.900% |
-701,723 (-1.45%) |
Filing |
| 2023-02-07 2:10 pm Sale |
2022-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
48,513,079 9.100% |
-1,533,266 (-3.06%) |
Filing |
| 2022-01-31 5:59 pm Purchase |
2021-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
50,046,345 8.900% |
2,240,551 (+4.69%) |
Filing |
| 2021-01-28 6:11 pm Purchase |
2020-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
47,805,794 8.200% |
1,549,297 (+3.35%) |
Filing |